Un cas d’infection à Clostridium difficile récidivante
Résumé
L’infection à Clostridium difficile (CD) est une affection nosocomiale commune. Malgré le succès du traitement initial, 15 à 25 % de patients vont récidiver. Le traitement de cette forme d’infection à CD peut être particulièrement problématique. Nous rapportons le cas d’une femme de 67 ans qui a développé une colite pseudomembraneuse (CPM) à CD avec plusieurs épisodes de récidives nous posant ainsi un problème thérapeutique.
Mots clés
Clostridium difficile Colite pseudomembraneuse Traitement RécidiveA case of recurrent Clostridium difficile disease
Abstract
Clostridium difficile (CD) infection is a common iatrogenic nosocomial disease. Despite successful treatment at the initial stage, 15–25% of the patients will have a relapse. Treatment of this form of CD infection can be particularly problematic. We report the case of a 67-year-old-woman developing a pseudomembranous colitis caused by CD with several relapses, posing to us a therapeutic problem.
Keywords
Clostridium difficile Pseudomembranous colitis Treatment RelapsePreview
Unable to display preview. Download preview PDF.
Références
- 1.Loo VG, Poirier L, Miller MA, et al (2005) A predominantly clonal multi-institutional outbreak of Clostridium difficile—associated diarrhoea with high morbidity and mortality. NEJM 353:2442–2449PubMedCrossRefGoogle Scholar
- 2.Monaghan T, Boswell T, Mahida YR (2008) Recent advances in Clostridium difficile—associated disease. Gut 57:850–860PubMedGoogle Scholar
- 3.Kelly CP, LaMont JT (2008) Clostridium difficile—more difficult than ever. NEJM 359:1932–1940PubMedCrossRefGoogle Scholar
- 4.L Kyne (2010) Clostridium difficile-beyond antibiotics. NEJM 362:264–265PubMedCrossRefGoogle Scholar
- 5.McFarland LV, Elmer GW, Surawicz CM (2002) Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97:1769–1775PubMedCrossRefGoogle Scholar
- 6.Kyne L, Kelly CP (2001) Recurrent Clostridium difficile diarrhoea. Gut 49(1):152–153PubMedCrossRefGoogle Scholar
- 7.Pépin J, Valiquette L, Gagnon S, et al (2007) Outcomes of Clostridium difficile—associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027. Am J Gastroenterol 102:2781–2788PubMedCrossRefGoogle Scholar
- 8.Leffler DA, Lamont JT (2009) Treatment of Clostridium difficile—associated disease. Gastroenterology 136:1899–1912PubMedCrossRefGoogle Scholar
- 9.Moshkowitz M, Ben-Baruch E, Kline Z, et al (2005) Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Colorectal Dis 9:173–177CrossRefGoogle Scholar
- 10.Lowy I, Molrine DC, Leav BA, et al (2010) Treatment with monoclonal antibodies against Clostridium difficile toxins. NEJM 362:197–205PubMedCrossRefGoogle Scholar
- 11.Shen EP, Surawicz CM (2007) The changing face of Clostridium difficile: what treatment options remain? Am J Gastroenterol 102:2789–2792PubMedCrossRefGoogle Scholar
- 12.McFarland LV (2006) Meta-analysis of probiotics for the prevention of antibiotic associated diarrhoea and the treatment of Clostridium difficile disease. Am J Gastroenterol 101:812–22PubMedCrossRefGoogle Scholar